Venue: Hotel d'Angleterre, Kongens Nytorv, Copenhagen
Date: 27/09/2018
Time: 10:00 - 15:00
Meet the experts: Ewoud-Jan van Hoogdalem, PRA Health Sciences; Mads Almose Røpke, Leo Pharma; Martin Bonde, Vaccibody; Iftekhar Khan, MHRA; Suzanne Pihl, Ascendis; Nils Piwon, and Jo Hulbert, PRA Health Sciences as we share perspectives in deciding the best early clinical development strategy based on mechanism of action, using adaptive & innovative designs. Discussions include rational use of biomarkers in the translational medicine mindset, tailored therapy, and drug evaluation.
